SCHEMBL1614810

SCHEMBL1614810

CCOC(=O)c1c(-c2ccc(Cl)cc2)nn2c(=O)cc(CCl)[nH]c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAT P00750 1/20 0.47
TP53 P04637 2/20 0.45
MDM2 Q00987 1/20 0.45
ALOX5 P09917 2/20 0.43
RXFP1 Q9HBX9 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.42
SIRT1 Q96EB6 1/20 0.42
SIRT3 Q9NTG7 1/20 0.42
ALPL P05186 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
PTGES O14684 1/20 0.41
GCGR P47871 1/20 0.40
ADORA3 P0DMS8 2/20 0.40
TSHR P16473 2/20 0.40
MAPT P10636 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15926346 0.91 PLAT (0.47) PLATTP53MDM2ALOX5RXFP1
SCHEMBL1279350 0.84 PLAT (0.46) PLATTP53MDM2ALOX5RXFP1
SCHEMBL1613899 0.82 PLAT (0.52) PLATRAB9AADORA3ALDH1A1MAPK1
SCHEMBL1615041 0.80 PLAT (0.47) PLATTP53MDM2ALOX5RXFP1
SCHEMBL1279125 0.78 PLAT (0.56) PLATALDH1A1
SCHEMBL1279349 0.74 MEN1 (0.43) PLATNPC1RAB9AMEN1KMT2A
SCHEMBL1278641 0.71 MEN1 (0.43) PLATALOX5NPC1RAB9AMEN1
SCHEMBL24834840 0.71 PLAT (0.40) PLATNPC1RAB9ASMN1; SMN2ADORA3
SCHEMBL1279271 0.70 MAPK14 (0.41) RXFP1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL23415553 0.69 PLAT (0.42) PLATNPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof KCNJ2, KCNQ5, KCNJ11 PLAT 1286/4885TP53 4179/4885MDM2 3635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.